For topical use on the surface of bleeding tissue only. Do not inject.
If the transfer device is used for reconstitution, transfer the diluent in the following manner:
CAUTION: Solutions should be used promptly upon removal from the container. However, the solution may be refrigerated at 2°C – 8°C for up to 24 hours, or may be stored at room temperature for up to 8 hours after reconstitution.
THROMBIN-JMI PUMP SPRAY KIT
Refer to THROMBIN-JMI Pump Spray Kit instructions for spray pump assembly and use.
Each spray kit contains one vial of THROMBIN-JMI, one vial of diluent and one spray pump and actuator.
THROMBIN-JMI SYRINGE SPRAY KIT
Refer to THROMBIN-JMI Syringe Spray Kit instructions for spray syringe assembly and use. Each syringe kit contains one vial of THROMBIN-JMI, one vial of diluent and one spray tip and syringe.
For use of THROMBIN-JMI 5,000 IU Syringe Spray Kit with GEL-FLOW™ NT:
THROMBIN-JMI EPISTAXIS KIT
Refer to THROMBIN-JMI Epistaxis Kit instructions for accessory assembly and use.
Each epistaxis kit contains one vial of THROMBIN-JMI, one vial of diluent and one nasal drug delivery device.
Topical application of THROMBIN-JMI
Use in conjunction with Absorbable Gelatin Sponge
Consult the Absorbable Gelatin Sponge, USP labeling for complete information for use prior to utilizing the following thrombin saturated sponge procedure.
For topical use on the surface of bleeding tissue only. Do not inject.
If the transfer device is used for reconstitution, transfer the diluent in the following manner:
CAUTION: Solutions should be used promptly upon removal from the container. However, the solution may be refrigerated at 2°C – 8°C for up to 24 hours, or may be stored at room temperature for up to 8 hours after reconstitution.
THROMBIN-JMI PUMP SPRAY KIT
Refer to THROMBIN-JMI Pump Spray Kit instructions for spray pump assembly and use.
Each spray kit contains one vial of THROMBIN-JMI, one vial of diluent and one spray pump and actuator.
THROMBIN-JMI SYRINGE SPRAY KIT
Refer to THROMBIN-JMI Syringe Spray Kit instructions for spray syringe assembly and use. Each syringe kit contains one vial of THROMBIN-JMI, one vial of diluent and one spray tip and syringe.
For use of THROMBIN-JMI 5,000 IU Syringe Spray Kit with GEL-FLOW™ NT:
THROMBIN-JMI EPISTAXIS KIT
Refer to THROMBIN-JMI Epistaxis Kit instructions for accessory assembly and use.
Each epistaxis kit contains one vial of THROMBIN-JMI, one vial of diluent and one nasal drug delivery device.
Topical application of THROMBIN-JMI
Use in conjunction with Absorbable Gelatin Sponge
Consult the Absorbable Gelatin Sponge, USP labeling for complete information for use prior to utilizing the following thrombin saturated sponge procedure.
For topical use on the surface of bleeding tissue only. Do not inject.
If the transfer device is used for reconstitution, transfer the diluent in the following manner:
CAUTION: Solutions should be used promptly upon removal from the container. However, the solution may be refrigerated at 2°C – 8°C for up to 24 hours, or may be stored at room temperature for up to 8 hours after reconstitution.
THROMBIN-JMI PUMP SPRAY KIT
Refer to THROMBIN-JMI Pump Spray Kit instructions for spray pump assembly and use.
Each spray kit contains one vial of THROMBIN-JMI, one vial of diluent and one spray pump and actuator.
THROMBIN-JMI SYRINGE SPRAY KIT
Refer to THROMBIN-JMI Syringe Spray Kit instructions for spray syringe assembly and use. Each syringe kit contains one vial of THROMBIN-JMI, one vial of diluent and one spray tip and syringe.
For use of THROMBIN-JMI 5,000 IU Syringe Spray Kit with GEL-FLOW™ NT:
THROMBIN-JMI EPISTAXIS KIT
Refer to THROMBIN-JMI Epistaxis Kit instructions for accessory assembly and use.
Each epistaxis kit contains one vial of THROMBIN-JMI, one vial of diluent and one nasal drug delivery device.
Topical application of THROMBIN-JMI
Use in conjunction with Absorbable Gelatin Sponge
Consult the Absorbable Gelatin Sponge, USP labeling for complete information for use prior to utilizing the following thrombin saturated sponge procedure.
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Contact Medical Information.9AM-5PM ET Monday to Friday; excluding holidays.
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.